contactenos@vnovamed.com.co

Referencias recomendadas:

  1. Leger D, Bonnefoy B, Pigearias B, de La Giclais B, Chartier A. Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children. Allergy Asthma Clin Immunol.(2017)
  2. Cingi C, Gevaert P, Mösges R, Rondon C, Hox V, Hupin C, et al.. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. (2017)
  3. Blaiss MS, Hammerby E, Robinson S, Kennedy-Martin T, Buchs S. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review. Ann Allergy Asthma Immunol.(2018)
  4. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al.. Rhinitis and onset of asthma: a longitudinal population-based study. (2008)
  5. Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, et al.. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007). Clin Exp Allergy.(2017)
  6. Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, et al.. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. (2013)
  7. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al.. Next- generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations, assessment, development and evaluation (GRADE)and real- world evidence.  Allergy Clin Immunol.(2020)
  8. Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al.. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol.(2020)
  9. Gough H, Grabenhenrich L, Reich A, Eckers N, Nitsche O, Schramm D, et al.. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol.(2015)
  10. Keller T, Hohmann C, Standl M, Wijga AH, Gehring U, Melén E, et al.. The sex-shift in single disease and multimorbid asthma and rhinitis during puberty – a study by MeDALL. (2018)
  11. Wahn U, Keil T, Grabenhenrich L. The development of allergic rhinitis in childhood. In: Sampson HA, Wahn U, editors. Allergy, Immunity and Tolerance in Early Childhood. Academic Press; (2016)
  12. Rotiroti G, Roberts G, Scadding GK. Rhinitis in children: common clinical presentations and differential diagnoses. Pediatr Allergy Immunol.(2015)
  13. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. (2011)
  14. Scadding GK, Hellings P, Alobid I, Bachert C, Fokkens W, van Wijk RG, et al.. Diagnostic tools in rhinology EAACI position paper. Clin Trans Allergy.(2011)
  15. Cipriani F, Tripodi S, Panetta V, Perna S, Potapova E, Dondi A, et al.. Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: a longitudinal multicenter study of a patient cohort. Pediatr Allergy Immunol.(2019)
  16. Scadding G K. Optimal management of allergic rhinitis. Arch Dis Child.(2015)
  17. Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, et al.. Efficacy of AzeFlu in children with seasonal allergic rhinitis: importance of paediatric symptom assessment. Pediatr Allergy Immunol.(2016)
  18. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mosges R. Nasal irrigation as anadjunctive treatment in allergic rhinitis: a systematic review and meta- analysis. Am J Rhinol Allergy.(2012)
  19. Head K, Snidvongs K, Glew S, Scadding G, Schilder AGM, Philpott C, et al.. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev.(2018)
  20. Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci.(2019)
  21. Meltzer EO, Blaiss M, Fairchild CJ. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis. Allergy Asthma Proc.(2011)
  22. Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Clin Ther.(2009)
  23. Wallace DV, Dykewicz MS. Comparing the evidence in allergic rhinitis guidelines. Curr Opin Allergy Clin Immunol.(2017)
  24. Blaiss MS. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc.(2011)
  25. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol.(2017)
  26. Zhao M, Li H, Li H. The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children. Eur Arch Otorhinolaryngol.(2021).
  27. Scadding GW, Scadding GK. Recent advances in antileukotriene therapy. Curr Opin Allergy Clin Immunol.(2010)
  28. Dennis RJ, Caraballo L, García E, Rojas MX, Rondon MA, Pérez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study. BMC Pulm Med 2012.

Vademécum